Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke

Stroke

Volumn 46, Issue 9, 2015, Pages 2591-2598

  Ganesalingam, Jeban ^a   Pizzo, Elena ^b   Morris, Stephen ^b   Sunderland, Tom ^c   Ames, Diane ^a   Lobotesis, Kyriakos ^d  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BOEHRINGER INGELHEIM LTD   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

cost effectiveness; stents; stroke; thrombectomy; tissue type plasminogen activator

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MECHANICAL THROMBECTOMY; MORTALITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SENSITIVITY ANALYSIS; STENT RETRIEVER; UNITED KINGDOM; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP; PROCEDURES; STENT; STROKE; THROMBECTOMY;

BRAIN ISCHEMIA; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; STENTS; STROKE; THROMBECTOMY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84940394550     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009396     Document Type: Article

References (46)

1. Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis. 2004;13:171-177. doi: 10.1016/j.jstrokecerebrovasdis.2004.06.003.
2. Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13:581-598. doi: 10.1111/j.1468-1331. 2006.01138.x.
3. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing. 2009;38:27-32. doi: 10.1093/ageing/afn281.
4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80.
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329. doi: 10.1056/NEJMoa0804656.
6. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engl J Med. 1995;333:1581-1587.
7. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11-20. doi: 10.1056/NEJMoa1411587.
8. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030. doi: 10.1056/NEJMoa1414905.
9. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792.
10. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285-2295. doi: 10.1056/NEJMoa1415061.
11. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296-2306. doi: 10.1056/NEJMoa1503780.
12. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973. doi: 10.1161/01. STR.0000258112.14918.24.
13. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC, et al; RECANALISE investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8:802-809. doi: 10.1016/S1474-4422(09)70182-6.
14. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al; Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-1212. doi: 10.1161/STROKEAHA.107.497115.
15. Poisson SN, Nguyen-Huynh MN, Johnston SC, Furie KL, Lev MH, Smith WS. Intracranial large vessel occlusion as a predictor of decline in functional status after transient ischemic attack. Stroke. 2011;42:44-47. doi: 10.1161/STROKEAHA.110.591099.
16. Broussalis E, Trinka E, Hitzl W, Wallner A, Chroust V, Killer-Oberpfalzer M. Comparison of stent-retriever devices versus the Merci retriever for endovascular treatment of acute stroke. AJNR Am J Neuroradiol. 2013;34:366-372. doi: 10.3174/ajnr.A3195.
17. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249. doi: 10.1016/S0140-6736(12)61384-1.
18. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240. doi: 10.1016/S0140-6736(12)61299-9.
19. Castaño C, Dorado L, Guerrero C, Millán M, Gomis M, Perez de la Ossa N, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke. 2010;41:1836-1840. doi: 10.1161/STROKEAHA.110.584904.
20. Costalat V, Machi P, Lobotesis K, Maldonado I, Vendrell JF, Riquelme C, et al. Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke. 2011;42:1929-1935. doi: 10.1161/STROKEAHA.110.608976.
21. Machi P, Costalat V, Lobotesis K, Maldonado IL, Vendrell JF, Riquelme C, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg. 2012;4: 62-66. doi: 10.1136/jnis.2010.004051.
22. Turk AS III, Campbell JM, Spiotta A, Vargas J, Turner RD, Chaudry MI, et al. An investigation of the cost and benefit of mechanical thrombectomy for endovascular treatment of acute ischemic stroke. J Neurointerv Surg. 2014;6:77-80. doi: 10.1136/neurintsurg-2012-010616.
23. Kim AS, Nguyen-Huynh M, Johnston SC. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke. 2011;42:2013-2018. doi: 10.1161/STROKEAHA.110.606889.
24. Nguyen-Huynh MN, Johnston SC. Is mechanical clot removal or disruption a cost-effective treatment for acute stroke? AJNR Am J Neuroradiol. 2011;32:244-249. doi: 10.3174/ajnr.A2329.
25. Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg. 2009;110:508-513. doi: 10.3171/2008.8.JNS08133.
26. Morris S, Devlin N, Parkin D. Economic Analysis in Healthcare. Chichester, West Sussex, United Kingdom: Wiley; 2012:295-299.
27. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. Published April 4, 2013. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9. Accessed June 1, 2014.
28. Purchasing power parties for gdp. http://www.oecd.org/std/ppp. Accessed December 1, 2014.
29. Curtis L. Unit Costs of Health and Social Care. Kent, UK: PSSRU, University of Kent; 2013:105-256
30. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. doi: 10.1161/STR. 0b013e318284056a.
31. British National Formulary. Alteplase. http://www.evidence.nhs.uk/formulary/bnf/current/2-cardiovascular-system/210-stable-angina-acutecoronary-syndromes-and-fibrinolysis/2102-fibrinolytic-drugs/alteplase. Accessed November 1, 2014.
32. National Institute for Health and Care Excellence. Submission by Boehringer Ingelheim to support the single technology appraisal by nice of alteplase for the treatment of acute ischaemic stroke (review of technology appraisal 122). September 2012. https://www.nice.org.uk/guidance/ta264/resources/guidance-alteplase-for-treating-acute-ischaemic-stroke-reviewof-technology-appraisal-guidance-122-pdf. Accessed June 1, 2014.
33. ScHARR. Alteplase for the treatment of acute ischaemic stroke (review of technology appraisal 122). http://www.nice.org.uk/guidance/ta264/resources/guidance-alteplase-for-treating-acute-ischaemic-strokereview-of-technology-appraisal-guidance-122-pdf. Accessed July 1, 2014.
34. Morris S, Hunter R, Davie C, Thompson A, Walker H, Thomson N, Mountford J. Cost-effectiveness analysis of the london stroke service. University College London Report. London, UK: University College London; 2011: 1-62
35. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke. 1997;28:1876-1882.
36. Neuro C. Codman Neuro revive SE thrombectomy device list price. 2013. http://www.depuysynthes.com/about/codman-neuro. Accessed June 1, 2014.
37. Neuro C. Codman Neuro revive se budget impact model detailed assumptions. 2013. http://www.depuysynthes.com/about/codman-neuro. Accessed June 1, 2014.
38. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
39. Royal College of Physicians. Sentinel Stroke National Audit Programme (SSNAP) Clinical Audit January-March 2014 Public Report. https://www.strokeaudit.org/results/national-results.aspx. Accessed October 2014.
40. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess. 2002; 6: 1-112.
41. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282. doi: 10.1016/S0140-6736(07)60149-4.
42. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. UK: Oxford University Press; 2006:78-118
43. Luengo-Fernandez R, Yiin GS, Gray AM, Rothwell PM. Population-based study of acute-and long-term care costs after stroke in patients with AF. Int J Stroke. 2013;8:308-314. doi: 10.1111/j.1747-4949.2012.00812.x.
44. Fields JD, Lutsep HL, Smith WS; MERCI Multi MERCI Investigators. Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI trials. AJNR Am J Neuroradiol. 2011;32:2170-2174. doi: 10.3174/ajnr.A2709.
45. Poisson SN, Glidden D, Johnston SC, Fullerton HJ. Deaths from stroke in US young adults, 1989-2009. Neurology. 2014;83:2110-2115. doi: 10.1212/WNL.0000000000001042.
46. Aarnio K, Haapaniemi E, Melkas S, Kaste M, Tatlisumak T, Putaala J. Long-term mortality after first-ever and recurrent stroke in young adults. Stroke. 2014;45:2670-2676. doi: 10.1161/STROKEAHA.114.005648.